Concentra Group Holdings Parent Inc (NYSE:CON)
$ 34.06 +3.52 (+11.53%) Market Cap: 4.36 Bil Enterprise Value: 6.37 Bil PE Ratio: 21.97 PB Ratio: 9.12 GF Score: 19/100

Q2 2026 Concentra Group Holdings Parent Inc Earnings Call Transcript

Aug 07, 2026 / 01:00PM GMT
Release Date Price: $34.06 (+11.53%)

Key Points

Positve
  • Total company revenue grew 10% year-over-year to $606 million, with core revenue up 8% excluding acquisitions.
  • Adjusted EBITDA increased 22.5% to $140.9 million, with margin expanding nearly 240 basis points to 23.3%.
  • Workers' compensation visit volume grew 3.7% and employer services visits increased 1.8%, indicating strong demand.
  • Onsite health clinics segment revenue surged 72.1% (27.9% organic), driven by strong pipeline and Pivot acquisition integration.
  • Net leverage ratio improved to under 3.0x, ahead of schedule, triggering a 25 basis point reduction in interest rate spread.
  • Company raised full-year 2026 guidance for revenue, adjusted EBITDA, and free cash flow due to strong performance.
  • Leadership transition plan is in place with Matt DiCanio set to become CEO, ensuring continuity and stability.
  • De novo expansion continues with new centers in Idaho and Kansas City, targeting 8-10 new sites in 2026 and double-digit in 2027.
  • Free cash flow nearly doubled to $121 million in Q2, driven by higher earnings and lower capital expenditures.
  • Separation from Select Medical is substantially complete, reducing ongoing costs and allowing focus on higher-value initiatives.
Negative
  • Workers' compensation visit growth rate moderated to 3.7% from 6.2% in Q1, indicating potential normalization.
  • Revenue per visit growth is expected to slow to around 3% for the remainder of the year, down from 4.6% in Q2.
  • The company faces ongoing costs related to the separation from Select Medical, though these are diminishing.
  • De novo centers contribute minimal revenue in the first 12-24 months, providing little near-term benefit.
  • The company's guidance implies a potential slowdown in EBITDA margins in the second half due to seasonality.
  • M&A pipeline is limited to mid-sized bolt-on acquisitions, with no large-scale deals like Nova expected.
  • The company's reliance on state regulatory rate increases (e.g., California, Tennessee) creates uncertainty for future pricing.
  • Employer services growth, while improved, remains below pre-pandemic levels, indicating potential economic headwinds.
  • The company's leverage reduction was aided by timing of payments, which may not be sustainable in future quarters.
  • The transition in CEO role, while planned, introduces execution risk during a period of strategic growth.
Operator

Good morning and thank you for joining us today for Concentra Group Holdings Parent Inc. Earnings Conference Call to discuss the second quarter 2026 results.

(Operator Instructions)

Speaking today are the company's Chief Executive Officer, Keith Newton, and the company's President and Chief Financial Officer, Matt DiCanio. Management will give you an overview and then open the call for questions.

Before we get started, we would like to remind you that this conference call may contain forward-looking statements regarding future events or the future financial performance of the company, including without limitation, statements regarding operating results, growth opportunities, and other statements that refer to Concentra's plans, expectations, strategies, intentions, and beliefs.

You are hereby cautioned that these forward-looking statements may be affected by the important factors among others set forth in Concentra's earnings release and in reports that are filed or furnished to the SEC. Consequently, actual operations and results may differ materially from those

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot